Panacos Pharmaceuticals (Panacos Pharmaceuticals) EV-to-EBIT : 0.00 (As of Jun. 20, 2024)

Panacos Pharmaceuticals EV-to-EBIT Chart

Panacos Pharmaceuticals Annual Data
	Trend	Dec98	Dec99	Dec00	Dec01	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07
EV-to-EBIT		Get a 7-Day Free Trial					-12.51	-2.56	-6.26	-3.64	-0.26

Panacos Pharmaceuticals Quarterly Data
	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08
EV-to-EBIT	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Panacos Pharmaceuticals's EV-to-EBIT

For the Biotechnology subindustry, Panacos Pharmaceuticals's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Panacos Pharmaceuticals's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panacos Pharmaceuticals's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Panacos Pharmaceuticals's EV-to-EBIT falls into.

Panacos Pharmaceuticals EV-to-EBIT Calculation

Panacos Pharmaceuticals's EV-to-EBIT for today is calculated as:

Panacos Pharmaceuticals's current Enterprise Value is $0.00 Mil.
Panacos Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Sep. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-34.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panacos Pharmaceuticals  (GREY:PANC) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Panacos Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2008 is calculated as:

Panacos Pharmaceuticals's Enterprise Value for the quarter that ended in Sep. 2008 was $7.95 Mil.
Panacos Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Sep. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-34.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panacos Pharmaceuticals EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Panacos Pharmaceuticals's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Panacos Pharmaceuticals (Panacos Pharmaceuticals) Business Description